The market-implied odds of 87.5% for no new pandemic in 2026 reflect the current absence of any novel pathogen demonstrating sustained human-to-human transmission capable of widespread global impact, according to ongoing CDC and WHO surveillance data. Respiratory virus activity this season, including influenza and COVID-19 variants, remains within expected ranges without the emergence of high-severity strains or zoonotic spillovers evolving into epidemics. Experts continue monitoring threats such as H5N1 avian influenza and other animal-origin viruses for potential mutations, yet confirmed case clusters stay localized with no evidence of accelerated spread or immune escape. Enhanced post-2020 surveillance systems and preparedness measures further support trader consensus that conditions through the remainder of the year are unlikely to trigger a new pandemic event.